|
US5744500A
(en)
|
1990-01-03 |
1998-04-28 |
Teva Pharmaceutical Industries, Ltd. |
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
|
|
IL118836A
(en)
|
1996-07-11 |
2001-01-11 |
Teva Pharma |
Pharmaceutical compositions comprising s-(-)-n-propargyl-1-aminoindan
|
|
IL149308A0
(en)
|
1999-10-27 |
2002-11-10 |
Teva Pharma |
Use of 1-aminoindan derivatives for treatment of manic disorders
|
|
SI1567152T1
(sl)
*
|
2002-11-15 |
2013-10-30 |
Teva Pharmaceutical Industries Ltd. |
Uporaba rasagilina z riluzolom za zdravljenje amiotrofične lateralne skleroze
|
|
GB2411355B
(en)
|
2004-02-27 |
2006-02-22 |
Niche Generics Ltd |
Pharmaceutical composition
|
|
WO2006014973A2
(en)
*
|
2004-07-26 |
2006-02-09 |
Teva Pharmaceutical Industries, Ltd. |
Pharmaceutical dosage forms including rasagiline
|
|
US8367105B2
(en)
|
2004-11-10 |
2013-02-05 |
Teva Pharmaceutical Industries, Ltd. |
Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
|
|
DE602004007302T2
(de)
*
|
2004-11-10 |
2008-03-20 |
Teva Pharmaceutical Industries Ltd. |
Verfahren zur herstellung von komprimierten festen dosierungsformen, das gut zur verwendung mit schlecht wasserlöslichen arzneistoffen geeignet ist, und danach hergestellte komprimierte feste dosierungsformen
|
|
CN103494766A
(zh)
*
|
2004-11-24 |
2014-01-08 |
特瓦制药工业有限公司 |
雷沙吉兰经口崩解组合物
|
|
WO2006089164A1
(en)
*
|
2005-02-17 |
2006-08-24 |
Teva Pharmaceutical Industries, Ltd. |
Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
|
|
US20100167983A1
(en)
*
|
2007-10-22 |
2010-07-01 |
Teva Pharmaceutical Industries, Ltd. |
Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
|
|
CA2901244A1
(en)
*
|
2005-02-23 |
2006-08-31 |
Teva Pharmaceutical Industries, Ltd. |
Rasagiline formulations of improved content uniformity
|
|
EP1954667B1
(en)
*
|
2005-11-17 |
2017-02-08 |
Teva Pharmaceutical Industries Ltd |
Methods for isolating propargylated aminoindans
|
|
US7572834B1
(en)
|
2005-12-06 |
2009-08-11 |
Teva Pharmaceutical Industries, Ltd. |
Rasagiline formulations and processes for their preparation
|
|
AU2006326642B2
(en)
|
2005-12-09 |
2012-05-03 |
Technion Research And Development Foundation Ltd. |
Use of low-dose ladostigil for neuroprotection
|
|
JP5701485B2
(ja)
|
2006-02-21 |
2015-04-15 |
テバ ファーマシューティカル インダストリーズ リミティド |
多系統萎縮症の治療のためのラサギリンの使用
|
|
TW200744576A
(en)
|
2006-02-24 |
2007-12-16 |
Teva Pharma |
Propargylated aminoindans, processes for preparation, and uses thereof
|
|
CA2646250A1
(en)
*
|
2006-04-03 |
2007-10-18 |
Teva Pharmaceutical Industries Ltd. |
Use of rasagiline for the treatment of restless legs syndrome
|
|
DE202006020710U1
(de)
|
2006-05-09 |
2009-12-31 |
Teva Pharmaceutical Industries Ltd. |
Zusammensetzungen mit Rosiglitazonmaleat
|
|
EP1892233A1
(de)
*
|
2006-08-18 |
2008-02-27 |
Ratiopharm GmbH |
Neue Salze des Wirkstoffs Rasagilin
|
|
JP5356248B2
(ja)
*
|
2006-12-14 |
2013-12-04 |
テバ ファーマシューティカル インダストリーズ リミティド |
ラサギリンのタンニン酸塩
|
|
ZA200903903B
(en)
*
|
2006-12-14 |
2010-08-25 |
Teva Pharma |
Crystalline solid rasagiline base
|
|
EP1987816A1
(de)
*
|
2007-04-30 |
2008-11-05 |
Ratiopharm GmbH |
Adsorbate eines Rasagilinsalzes mit einem wasserlöslichen Hilfsstoff
|
|
AU2008296908B2
(en)
*
|
2007-09-05 |
2014-01-09 |
Teva Pharmaceutical Industries, Ltd. |
Method of treating glaucoma using rasagiline
|
|
US8188149B2
(en)
*
|
2007-09-17 |
2012-05-29 |
Teva Pharmaceutical Industries, Ltd. |
Use of R(+)-N-propargy1-1-aminoindan to treat or prevent hearing loss
|
|
US20090181086A1
(en)
*
|
2008-01-11 |
2009-07-16 |
Muhammad Safadi |
Rasagiline formulations, their preparation and use
|
|
US20090247537A1
(en)
*
|
2008-03-25 |
2009-10-01 |
William Dale Overfield |
Methods for preventing or treating bruxism using dopaminergic agents
|
|
WO2009122301A2
(en)
*
|
2008-03-31 |
2009-10-08 |
Actavis Group Ptc Ehf |
Rasagiline mesylate particles and process for the preparation thereof
|
|
JP2011522892A
(ja)
*
|
2008-06-13 |
2011-08-04 |
テバ ファーマシューティカル インダストリーズ リミティド |
パーキンソン病緩和のためのラサギリン
|
|
MX2010013875A
(es)
|
2008-06-19 |
2011-01-20 |
Teva Pharma |
Proceso para preparar y secar base de rasagilina solida.
|
|
AU2009260733B2
(en)
*
|
2008-06-19 |
2015-01-29 |
Teva Pharmaceutical Industries, Ltd. |
Process for purifying rasagiline base
|
|
US20100189790A1
(en)
*
|
2009-01-23 |
2010-07-29 |
Teva Pharmaceutical Industries, Ltd. |
Delayed release rasagiline formulation
|
|
EP2218444A3
(en)
|
2009-01-23 |
2010-08-25 |
Teva Pharmaceutical Industries, Ltd. |
Delayed release rasagiline formulation
|
|
US20120122993A1
(en)
|
2009-03-05 |
2012-05-17 |
Sandoz Ag |
Pharmaceutical composition containing 1h-inden-1-amine, 2,3-dihydro-n-2-propynyl-(1r)-, methanesulfonate
|
|
SI2451771T1
(sl)
|
2009-07-09 |
2014-10-30 |
Ratiopharm Gmbh |
Soli rasagilina in njihovi farmacevtski pripravki
|
|
CN102048717B
(zh)
†
|
2009-10-29 |
2014-02-19 |
重庆医药工业研究院有限责任公司 |
一种稳定的雷沙吉兰组合物
|
|
AU2010341499A1
(en)
|
2009-12-22 |
2012-08-09 |
Teva Pharmaceutical Industries Ltd. |
3-keto-N-propargyl-1-aminoindan
|
|
ES2608782T3
(es)
|
2010-04-30 |
2017-04-17 |
Teikoku Pharma Usa, Inc. |
Composiciones transdérmicas de propinilaminoindano
|
|
EP2389927A1
(en)
|
2010-05-30 |
2011-11-30 |
Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi |
Pharmaceutical formulations of rasagiline
|
|
AU2011282716A1
(en)
|
2010-07-27 |
2013-03-14 |
Teva Pharmaceutical Industries Ltd. |
Dispersions of rasagiline citrate
|
|
CA2806740A1
(en)
|
2010-07-27 |
2012-02-02 |
Teva Pharmaceutical Industries Ltd. |
Use of rasagiline for the treatment of olfactory dysfunction
|
|
EP2688561B1
(en)
|
2011-03-24 |
2018-08-22 |
Teikoku Pharma USA, Inc. |
Transdermal compositions comprising an active agent layer and an active agent conversion layer
|
|
JP2014534197A
(ja)
|
2011-10-10 |
2014-12-18 |
テバ ファーマシューティカル インダストリーズ リミティド |
Ｒ（＋）−ｎ−メチル−プロパルギルアミノインダン
|
|
CN103857389A
(zh)
*
|
2011-10-10 |
2014-06-11 |
泰华制药工业有限公司 |
雷沙吉兰柠檬酰胺
|
|
WO2013055687A2
(en)
|
2011-10-10 |
2013-04-18 |
Teva Pharmaceutical Industries Ltd. |
R(+)-n-formyl-propargyl-aminoindan
|
|
JP5913614B2
(ja)
|
2011-11-09 |
2016-04-27 |
テイコク ファーマ ユーエスエー インコーポレーテッド |
皮膚新生物の処置方法
|
|
DE102012000786A1
(de)
|
2012-01-18 |
2013-07-18 |
Stada Arzneimittel Ag |
Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung, enthaltend den Wirkstoff Rasagilin
|
|
EA201491734A1
(ru)
|
2012-03-21 |
2015-01-30 |
Синтон Бв |
Стабилизированные фармацевтические композиции, содержащие соли разагилина
|
|
WO2013175493A1
(en)
|
2012-04-09 |
2013-11-28 |
Cadila Healthcare Limited |
Stable oral pharmaceutical compositions
|
|
US9308182B2
(en)
|
2012-08-17 |
2016-04-12 |
Teva Pharmaceutical Industries, Ltd. |
Parenteral formulations of rasagiline
|
|
AU2013338243B2
(en)
|
2012-11-02 |
2016-09-29 |
Teikoku Seiyaku Co., Ltd. |
Propynylaminoindan transdermal compositions
|
|
EP2796130A3
(en)
*
|
2013-02-06 |
2015-02-25 |
Galenicum Health S.L. |
Immediate release tablets of rasagiline hemitartrate
|
|
ES2502140T1
(es)
*
|
2013-02-06 |
2014-10-02 |
Galenicum Health S.L. |
Comprimidos de liberación inmediata de rasagilina hemitartrato
|
|
CN115400090A
(zh)
*
|
2022-10-09 |
2022-11-29 |
北京新领先医药科技发展有限公司 |
一种雷沙吉兰的口崩片组合物及其制备方法
|